Search research articles
Contact Us
Filters
Showing results (1-10 of 304) with videos related to
Page
of 31
Sort By:
International Journal of Urology : Official Journal of the Japanese Urological Association
|
August 13, 2020
Editorial Comment from Dr Kondo to Partial nephrectomy preserves renal function without increasing the risk of complications compared with radical nephrectomy for renal cell carcinomas of stages pT2-3a
Tsunenori Kondo
International Journal of Urology : Official Journal of the Japanese Urological Association
|
November 11, 2025
Editorial Comment to Impact of Prolonged Warm Ischemia During Clamped Partial Nephrectomy: Comparison Between Japanese and American Cohorts
Tsunenori Kondo
International Journal of Urology : Official Journal of the Japanese Urological Association
|
July 15, 2023
Editorial Comment to Efficacy and safety of pembrolizumab and axitinib as first-line treatment for patients with advanced renal cell carcinoma: Real-world experience in Japan
Tsunenori Kondo
International Journal of Urology : Official Journal of the Japanese Urological Association
|
February 11, 2021
Editorial Comment from Dr Kondo to Clinical utility of head computed tomography scan during systemic therapy for metastatic renal cell carcinoma
Tsunenori Kondo
International Journal of Urology : Official Journal of the Japanese Urological Association
|
March 1, 2024
Editorial Comment to Real-world sequential treatment patterns and clinical outcomes among patients with advanced urothelial carcinoma in Japan
Tsunenori Kondo
International Journal of Urology : Official Journal of the Japanese Urological Association
|
September 21, 2023
Editorial Comment to Neocapsular reconstruction for challenging partial nephrectomy: A feasibility study in a porcine model and recent clinical experience
Tsunenori Kondo
International Journal of Urology : Official Journal of the Japanese Urological Association
|
March 22, 2020
Editorial Comment to Inflammatory markers for predicting responses to nivolumab in patients with metastatic renal cell carcinoma
Tsunenori Kondo
The Lancet. Oncology
|
April 7, 2022
Is tailored systemic therapy in renal cell carcinoma realistic?
Tsunenori Kondo
International Journal of Urology : Official Journal of the Japanese Urological Association
|
April 30, 2026
Editorial Comment to the Impact of the Relevant Factors as High-Complexity Tumors in Robot-Assisted Partial Nephrectomy
Tsunenori Kondo
International Journal of Urology : Official Journal of the Japanese Urological Association
|
April 30, 2026
Editorial Comment to Real-World Effectiveness and Safety of Pembrolizumab-Lenvatinib Versus Axitinib-Based Regimens in Metastatic Clear Cell Renal Cell Carcinoma: A Multicenter Retrospective Study
Tsunenori Kondo
Page
of 31
Search research articles
Search
Showing results (1-10 of 304) with videos related to
Sort By:
Page
of 31
International Journal of Urology : Official Journal of the Japanese Urological Association
|
August 13, 2020
Editorial Comment from Dr Kondo to Partial nephrectomy preserves renal function without increasing the risk of complications compared with radical nephrectomy for renal cell carcinomas of stages pT2-3a
Tsunenori Kondo
International Journal of Urology : Official Journal of the Japanese Urological Association
|
November 11, 2025
Editorial Comment to Impact of Prolonged Warm Ischemia During Clamped Partial Nephrectomy: Comparison Between Japanese and American Cohorts
Tsunenori Kondo
International Journal of Urology : Official Journal of the Japanese Urological Association
|
July 15, 2023
Editorial Comment to Efficacy and safety of pembrolizumab and axitinib as first-line treatment for patients with advanced renal cell carcinoma: Real-world experience in Japan
Tsunenori Kondo
International Journal of Urology : Official Journal of the Japanese Urological Association
|
February 11, 2021
Editorial Comment from Dr Kondo to Clinical utility of head computed tomography scan during systemic therapy for metastatic renal cell carcinoma
Tsunenori Kondo
International Journal of Urology : Official Journal of the Japanese Urological Association
|
March 1, 2024
Editorial Comment to Real-world sequential treatment patterns and clinical outcomes among patients with advanced urothelial carcinoma in Japan
Tsunenori Kondo
International Journal of Urology : Official Journal of the Japanese Urological Association
|
September 21, 2023
Editorial Comment to Neocapsular reconstruction for challenging partial nephrectomy: A feasibility study in a porcine model and recent clinical experience
Tsunenori Kondo
International Journal of Urology : Official Journal of the Japanese Urological Association
|
March 22, 2020
Editorial Comment to Inflammatory markers for predicting responses to nivolumab in patients with metastatic renal cell carcinoma
Tsunenori Kondo
The Lancet. Oncology
|
April 7, 2022
Is tailored systemic therapy in renal cell carcinoma realistic?
Tsunenori Kondo
International Journal of Urology : Official Journal of the Japanese Urological Association
|
April 30, 2026
Editorial Comment to the Impact of the Relevant Factors as High-Complexity Tumors in Robot-Assisted Partial Nephrectomy
Tsunenori Kondo
International Journal of Urology : Official Journal of the Japanese Urological Association
|
April 30, 2026
Editorial Comment to Real-World Effectiveness and Safety of Pembrolizumab-Lenvatinib Versus Axitinib-Based Regimens in Metastatic Clear Cell Renal Cell Carcinoma: A Multicenter Retrospective Study
Tsunenori Kondo
Page
of 31